-
Symbol
-
CVAC
-
Investment type
-
Equity / Common Shares, par value (euro)0.12 per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
GSK plc ownership in CureVac N.V. Common Shares, par value (euro)0.12 per share (CVAC)
05 Dec 2025 - GSK plc has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of CureVac N.V. Common Shares, par value (euro)0.12 per share (CVAC).
This represents 0% ownership of the company.
In their previous filing dated 13 Aug 2025, GSK plc had reported owning 16,591,937 shares, indicating a decrease of +100%.
.